West Kendall Baptist Hospital – Scholarly Showcase Evaluation - August 28, 2019

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	0
The information and/or skills learned will enhance my professional competence or ability.	The information and/or skills learned will enhance my professional competence or ability. - 5	The information and/or skills learned will enhance my professional competence or ability. - 4	The information and/or skills learned will enhance my professional competence or ability. - 3	The information and/or skills learned will enhance my professional competence or ability. - 2	The information and/or skills learned will enhance my professional competence or ability. - 1	The information and/or skills learned will enhance my professional competence or ability. - 0
This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients.	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 5	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 4	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 3	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 2	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 1	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 0

As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree NA=Not applicable to my practice

	5	4	3	2	1	NA
Describe the pathophysiology of common oncologic emergencies.	Describe the pathophysiology of common oncologic emergencies. - 5	Describe the pathophysiology of common oncologic emergencies. - 4	Describe the pathophysiology of common oncologic emergencies. - 3	Describe the pathophysiology of common oncologic emergencies. - 2	Describe the pathophysiology of common oncologic emergencies. - 1	Describe the pathophysiology of common oncologic emergencies. - NA
Identify signs, symptoms, and complications which result from ineffective chemotherapy.	Identify signs, symptoms, and complications which result from ineffective chemotherapy. - 5	Identify signs, symptoms, and complications which result from ineffective chemotherapy. - 4	Identify signs, symptoms, and complications which result from ineffective chemotherapy. - 3	Identify signs, symptoms, and complications which result from ineffective chemotherapy. - 2	Identify signs, symptoms, and complications which result from ineffective chemotherapy. - 1	Identify signs, symptoms, and complications which result from ineffective chemotherapy. - NA
Implement pharmacological strategies for cancer patients presenting with disease related symptoms.	Implement pharmacological strategies for cancer patients presenting with disease related symptoms. - 5	Implement pharmacological strategies for cancer patients presenting with disease related symptoms. - 4	Implement pharmacological strategies for cancer patients presenting with disease related symptoms. - 3	Implement pharmacological strategies for cancer patients presenting with disease related symptoms. - 2	Implement pharmacological strategies for cancer patients presenting with disease related symptoms. - 1	Implement pharmacological strategies for cancer patients presenting with disease related symptoms. - NA
Explain mechanism of action for targeted IV immunotherapy.	Explain mechanism of action for targeted IV immunotherapy. - 5	Explain mechanism of action for targeted IV immunotherapy. - 4	Explain mechanism of action for targeted IV immunotherapy. - 3	Explain mechanism of action for targeted IV immunotherapy. - 2	Explain mechanism of action for targeted IV immunotherapy. - 1	Explain mechanism of action for targeted IV immunotherapy. - NA
Implement treatment modalities utilized in patients with immune related adverse events (IRAE).	Implement treatment modalities utilized in patients with immune related adverse events (IRAE). - 5	Implement treatment modalities utilized in patients with immune related adverse events (IRAE). - 4	Implement treatment modalities utilized in patients with immune related adverse events (IRAE). - 3	Implement treatment modalities utilized in patients with immune related adverse events (IRAE). - 2	Implement treatment modalities utilized in patients with immune related adverse events (IRAE). - 1	Implement treatment modalities utilized in patients with immune related adverse events (IRAE). - NA
Execute the requirements of the United States Pharmacopeia on receiving, storing, and transporting hazardous drugs.	Execute the requirements of the United States Pharmacopeia on receiving, storing, and transporting hazardous drugs. - 5	Execute the requirements of the United States Pharmacopeia on receiving, storing, and transporting hazardous drugs. - 4	Execute the requirements of the United States Pharmacopeia on receiving, storing, and transporting hazardous drugs. - 3	Execute the requirements of the United States Pharmacopeia on receiving, storing, and transporting hazardous drugs. - 2	Execute the requirements of the United States Pharmacopeia on receiving, storing, and transporting hazardous drugs. - 1	Execute the requirements of the United States Pharmacopeia on receiving, storing, and transporting hazardous drugs. - NA

Rate the following *

Scoring Key: 5=Excellent 4=Very Good 3=Good 2=Fair 1=Poor

	5	4	3	2	1
Course content.	Course content. - 5	Course content. - 4	Course content. - 3	Course content. - 2	Course content. - 1
Alyssa Donadio, Pharm.D., BCPS	Alyssa Donadio, Pharm.D., BCPS - 5	Alyssa Donadio, Pharm.D., BCPS - 4	Alyssa Donadio, Pharm.D., BCPS - 3	Alyssa Donadio, Pharm.D., BCPS - 2	Alyssa Donadio, Pharm.D., BCPS - 1
Mariadela Matute, APRN, MSN, OCN, BMT-CN	Mariadela Matute, APRN, MSN, OCN, BMT-CN - 5	Mariadela Matute, APRN, MSN, OCN, BMT-CN - 4	Mariadela Matute, APRN, MSN, OCN, BMT-CN - 3	Mariadela Matute, APRN, MSN, OCN, BMT-CN - 2	Mariadela Matute, APRN, MSN, OCN, BMT-CN - 1
Christine Ibarra, Pharm.D., BCPS	Christine Ibarra, Pharm.D., BCPS - 5	Christine Ibarra, Pharm.D., BCPS - 4	Christine Ibarra, Pharm.D., BCPS - 3	Christine Ibarra, Pharm.D., BCPS - 2	Christine Ibarra, Pharm.D., BCPS - 1
Lilit Smith, Pharm.D., MBA	Lilit Smith, Pharm.D., MBA - 5	Lilit Smith, Pharm.D., MBA - 4	Lilit Smith, Pharm.D., MBA - 3	Lilit Smith, Pharm.D., MBA - 2	Lilit Smith, Pharm.D., MBA - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

1-5

6-10

Over 10

Not applicable to my practice

Please list specific changes you intend to implement in your daily practice as a result of attending this activity. *

If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so. *

List topics related to this lecture that you want to learn more about?

Comments

Name

You are here

West Kendall Baptist Hospital – Scholarly Showcase Evaluation - August 28, 2019